[Federal Register Volume 88, Number 35 (Wednesday, February 22, 2023)]
[Notices]
[Pages 10905-10906]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03604]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Recharter for Advisory Council on Blood Stem Cell Transplantation

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act (FACA), 
the Department of Health and Human Services is hereby giving notice 
that the Advisory Council on Blood Stem Cell Transplantation (ACBSCT) 
has been rechartered. The effective date of the recharter is February 
19, 2023.

FOR FURTHER INFORMATION CONTACT: Shelley Tims Grant (Designated Federal 
Officer); HRSA Division of Transplantation, HRSA, 5600 Fishers Lane, 
08W67, Rockville, Maryland 20857; 301-443-8036; or [email protected].

SUPPLEMENTARY INFORMATION: The ACBSCT advises, assists, consults with, 
and makes recommendations to the Secretary of Health and Human 
Services, acting through the HRSA Administrator, on matters related to 
the activities of the C.W. Bill Young Cell Transplantation Program and 
National Cord Blood Inventory and other matters of significance 
concerning the activities under section 379 of the Public Health 
Service Act (42 U.S.C. 274k).
    The ACBSCT shall provide a consolidated, comprehensive source of 
expert, unbiased analysis, and recommendations to the Secretary of 
Health and Human Services on the latest advances in the science of 
blood

[[Page 10906]]

stem cell transplantation and donation. The ACBSCT may also review the 
state of the science using adult stem cells and birthing tissues to 
develop new types of therapies for patients, for the purpose of 
considering the potential inclusion of such new types of therapies in 
the C.W. Bill Young Cell Transplantation Program.
    The recharter for ACBSCT was approved on February 15, 2023. 
Recharter of the ACBSCT charter gives authorization for the ACBSCT to 
operate until February 19, 2025.
    A copy of the ACBSCT charter is available on the ACBSCT website at 
https://bloodstemcell.hrsa.gov/about/advisory-council. A copy of the 
charter can also be obtained by accessing the FACA database that is 
maintained by the Committee Management Secretariat under the General 
Services Administration. The website address for the FACA database is 
http://www.facadatabase.gov/.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023-03604 Filed 2-21-23; 8:45 am]
BILLING CODE 4165-15-P